Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RenovoDerm
AddedFeb 17, 2024
UpdatedJun 18, 2026
RenovoDerm

RenovoDerm

Angel

RenovoDerm: Ohio-based medical firm specializing in advanced wound care products since 2016.

HQ
Columbus, OH, US
Founded
2016
Overview
Compare
Fundraising
Employees

RenovoDerm is a medical company specializing in advanced wound care products that provide a structure for tissue growth and promote faster healing. Founded in 2016 and headquartered in Columbus, Ohio, the company focuses on innovative solutions for the healthcare market.

RenovoDerm has made significant strides in the medical field, contributing to improved patient outcomes with their cutting-edge products. Their impact is evident in the enhanced healing rates and quality of life for patients using their technology.

RenovoDerm - Similar Companies

Newco Wound Care logo

Newco Wound Care

Dermal Life logo

Dermal Life

WoundForce logo

WoundForce

Biowound Solutions logo

Biowound Solutions

Lotus Tissue Repair logo

Lotus Tissue Repair

Eluciderm logo

Eluciderm

eluciderm.com

Regenerex Pharma logo

Regenerex Pharma

Renerva logo

Renerva

renerva.com

Renovo Concepts logo

Renovo Concepts

renovoconcepts.com

Wound Care Technologies logo

Wound Care Technologies

Emunamedica logo

Emunamedica

O2 RegenTech logo

O2 RegenTech

PluroGen Therapeutics logo

PluroGen Therapeutics

Encore Dermatology logo

Encore Dermatology

NovaDerm Aid logo

NovaDerm Aid

RenovoDerm - Quick Facts

Who are RenovoDerm's competitors?

Companies similar to RenovoDerm include Newco Wound Care, Dermal Life, WoundForce and Biowound Solutions.

When was RenovoDerm founded?

RenovoDerm was founded in 2016.

Where is RenovoDerm's headquarters located?

RenovoDerm's headquarters is located in Columbus, OH, US.

When was RenovoDerm's last funding round?

RenovoDerm's most recent funding round was for $100k (USD) in February 2023.

How much has RenovoDerm raised to-date?

As of Feb 8, 2023, RenovoDerm has raised a total of $100k (USD).

How many employees does RenovoDerm have?

RenovoDerm has 8 employees as of Feb 5, 2024.

RenovoDerm - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Wound Care
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine